BC Platforms and NTT Life Science Corporation form an exclusive collaboration to drive data-driven medicine and strengthen Real-World Data capabilities worldwide.
BC Platforms acquires Medexprim, expanding our ability to deliver secure access to Real-World clinical and imaging Data for global biopharma across Europe.
BC Platforms strengthens its global offering with the acquisition of 4Pharma, combining CRO expertise with advanced Real-World Data technology.
BC Platforms secures CHF 20 million in new financing led by Jolt Capital to accelerate innovation and scale our healthcare data and analytics capabilities worldwide.